SEC Tracker
Get the app

ENDRA Life Sciences NDRA

Asp Isotopes discusses merger plans

Merger communication

Form
425
Filed
Importance
Routine
  1. Renergen plant is operational and producing liquid helium and natural gas.
  2. Phase 2 contracts with customers are expected to be signed by mid-2027.
  3. Company plans to divest into Noble Energy and QLE to reduce conglomerate discount.
  4. Helium strategy involves balancing spot market and long-term contracts.

Written from the 425 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when ENDRA Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. Global Innovative Platforms GIPL public float $3M, Sep 30, 2025
  2. Interpace Biosciences IDXG public float $3M, Jun 30, 2025
  3. Bluejay Diagnostics BJDX public float $3M, Jun 30, 2025
  4. Stimcell Energetics STME public float $2M, Nov 30, 2025
  5. LogicMark LGMK public float $2M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.